Literature DB >> 10072260

Urokinase is required for T lymphocyte proliferation and activation in vitro.

M R Gyetko1, E A Libre, J A Fuller, G H Chen, G Toews.   

Abstract

We have previously demonstrated that urokinase-deficient (uPA-/-) mice do not increase lung T lymphocyte number and fail to mount protective immune responses during pulmonary Cryptococcus neoformans infection. These observations suggest a previously unconsidered role for urokinase-type plasminogen activator (uPA) in T lymphocyte-mediated immune responses. Accordingly, we sought to determine whether uPA is required for T cell receptor-mediated (TCR-mediated) lymphocyte proliferation and activation. Splenocytes from uPA-/- and uPA+/+ mice were stimulated with concanavalin A (Con A). The uPA-/- mice had diminished T cell proliferation as compared with uPA+/+ mice. Coculturing uPA-/- T cells with uPA+/+ accessory cells led to the restoration of proliferation. Similarly, T cell proliferation induced by CD3 cross-linking was diminished in uPA-/- mice as compared with uPA+/+ mice. T lymphocyte activation, defined as the induced expression of antigens and the elaboration of cytokines, was determined. The expression of CD69 and that of CD49d were diminished in response to Con A stimulation in uPA-/- mice as compared with uPA+/+ mice. The elaboration of cytokines in response to Con A was also altered in the uPA-/- mice. The production of the Th1 cytokines interferon-gamma and interleukin-12 was diminished in uPA-/- mice as compared with uPA+/+ mice. The uPA-/- mice produced increased amounts of interleukin-10, a Th2 cytokine. We conclude that the lack of uPA results in impaired T cell activation and proliferation in response to TCR-mediated signaling and the expression of a less Th1-polarized profile of cytokines. These findings suggest that the inability of uPA-/- mice to combat Cryptococcus neoformans infection may be caused by the impairment of T lymphocyte immune responses in the absence of uPA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072260     DOI: 10.1016/s0022-2143(99)90084-7

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  9 in total

1.  Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis.

Authors:  Andrew D Cook; Emma L Braine; Ian K Campbell; John A Hamilton
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

2.  Urokinase-deficient mice fail to generate a type 2 immune response following schistosomal antigen challenge.

Authors:  Margaret R Gyetko; Sudha Sud; Stephen W Chensue
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

3.  Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement.

Authors:  Andrew D Cook; Christine M De Nardo; Emma L Braine; Amanda L Turner; Ross Vlahos; Kerrie J Way; S Kaye Beckman; Jason C Lenzo; John A Hamilton
Journal:  Arthritis Res Ther       Date:  2010-03-02       Impact factor: 5.156

4.  Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells.

Authors:  Massimo Alfano; Samanta A Mariani; Chiara Elia; Ruggero Pardi; Francesco Blasi; Guido Poli
Journal:  Blood       Date:  2008-10-21       Impact factor: 22.113

5.  Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication.

Authors:  Massimo Alfano; Nicolai Sidenius; Barbara Panzeri; Francesco Blasi; Guido Poli
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

6.  PLAU inferred from a correlation network is critical for suppressor function of regulatory T cells.

Authors:  Feng He; Hairong Chen; Michael Probst-Kepper; Robert Geffers; Serge Eifes; Antonio Del Sol; Klaus Schughart; An-Ping Zeng; Rudi Balling
Journal:  Mol Syst Biol       Date:  2012       Impact factor: 11.429

7.  Urokinase, a constitutive component of the inflamed synovial fluid, induces arthritis.

Authors:  Tao Jin; Andrej Tarkowski; Peter Carmeliet; Maria Bokarewa
Journal:  Arthritis Res Ther       Date:  2002-10-17       Impact factor: 5.156

8.  Reduced Expression of Urokinase Plasminogen Activator in Brown Adipose Tissue of Obese Mouse Models.

Authors:  Chung-Ze Wu; Li-Chien Chang; Chao-Wen Cheng; Te-Chao Fang; Yuh-Feng Lin; Dee Pei; Jin-Shuen Chen
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

9.  Association among Fibrinolytic Proteins, Metabolic Syndrome Components, Insulin Secretion, and Resistance in Schoolchildren.

Authors:  Jin-Shuen Chen; Chung-Ze Wu; Nain-Feng Chu; Li-Chien Chang; Dee Pei; Yuh-Feng Lin
Journal:  Int J Endocrinol       Date:  2015-11-08       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.